Delivery Order SPE2DB20D3304-SPE2DB24FW7D3
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, valued at $1,740.46. The contract is for the supply of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $11,358 and an ultimate completion date of November 20, 2024. This is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,152.92 firm-fixed-price contract is for the supply of ondansetron orally disintegrating tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,404.80 and a completion date of April 3, 2025. It is a firm fixed-price contract with no set-aside designation, indicating...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,962.53. The contract is for the supply of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $17,496.87 and an ultimate completion date of February 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,670.28, is for the supply of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,634.56, is for the supply of ondansetron orally disintegrating tablets to support federal healthcare programs. It is a firm fixed-price contract with a period of performance through January 27, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,079.55 contract is for the supply of 4 milligram Ondansetron orally disintegrating tablets, a common medication used to prevent nausea and vomiting. The contract has a completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a ceiling value of $3,482.29 and a performance period that runs through January 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a...